Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...

Since April 2021, the S&P 500 has delivered a total return of 68.6%. But one standout stock has more than doubled the market ...

Tectonic Therapeutic is reviving relaxin biology with TX45, targeting Group 2 Pulmonary Hypertension with HFpEF. Check out ...

Allrock Bio has dosed the first participants in a small clinical trial testing ROC-101 as an add-on treatment for pulmonary ...

Cautionary Language Concerning Forward-Looking Statements ...

Finance News; GSK completes purchase of Canada's 35Pharma for USD950 million; GSK completes purchase of Canada's 35Pharma for USD950 million ...

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

A recent study published in CHEST found that treatment-naïve adults with obesity-hypoventilation syndrome receiving a ...

Cardiology experts from UCSF Health presented new research and clinical findings at the American College of Cardiology’s (ACC) Annual Scientific Session and Expo in New Orleans, March 28 to 30. The ...

In a phase 2 trial, treatment with sotatercept shows reduced pulmonary vascular resistance and heart outcomes in patients ...

Scientists have created a new "molecular map" uncovering how an important human receptor involved in blood clotting and ...

A diagnosis of Leigh syndrome is often devastating for families. The rare genetic disorder steadily robs the brain and ...